PFIZER INC
Insider CIK 78003 · CLDN 10% owner · AQXP 10% owner · FLXN 10% owner · MIRN 10% owner · ZTS Director, 10% owner · RYTM 10% owner · CRTX 10% owner · IMRA 10% owner · ALLO 10% owner · SWTX 10% owner · PYXS 10% owner · VTRS 10% owner · CERF 10% owner · BCAB 10% owner · ICUI Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CERE Cerevel Therapeutics Holdi | U Tender | 2024-08-01 | 2024-08-05 | 27,349,211 | $45.00 | $1.23B | 0 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | P Buy | 2023-03-17 | 2023-03-21 | 1,811,594 | $2.76 | $5.00M | 5,952,263 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | P Buy | 2023-03-17 | 2023-03-23 | 1,811,594 | $2.76 | $5.00M | 5,952,263 | SEC↗ |
| BCAB BioAtla, Inc. | C Conversion deriv | 2020-12-18 | 2020-12-22 | 2,238,090 | — | $0 | 0 | SEC↗ |
| BCAB BioAtla, Inc. | C Conversion | 2020-12-18 | 2020-12-22 | 2,238,090 | — | $0 | 2,238,090 | SEC↗ |
| VTRS Viatris Inc | J Other | 2020-11-16 | 2020-11-16 | 689,874,047 | — | $0 | 0 | SEC↗ |
| VTRS Viatris Inc | J Other | 2020-11-13 | 2020-11-16 | 689,873,947 | — | $0 | 689,874,047 | SEC↗ |
| CERF Cerevel Therapeutics Holdi | P Buy | 2020-10-27 | 2020-10-29 | 1,200,000 | $10.00 | $12.00M | 27,349,211 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2020-06-03 | 2020-06-04 | 370,000 | $40.18 | $14.87M | 2,879,973 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 5,470,492 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 478,749 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 1,894,444 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 300,752 | — | $0 | 1,169,219 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 868,467 | — | $0 | 868,467 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 76,003 | — | $0 | 76,003 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2020-03-16 | 2020-03-16 | 312,500 | $16.00 | $5.00M | 1,481,719 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 6,437,500 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 3,465,571 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 20,000,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 3,039,051 | — | $0 | 4,017,245 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 978,194 | — | $0 | 978,194 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 526,602 | — | $0 | 4,543,847 | SEC↗ |
| SWTX SpringWorks Therapeutics, | P Buy | 2019-09-17 | 2019-09-19 | 50,000 | $18.00 | $900.0K | 4,593,847 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-14 | 624,205 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-14 | 215,697 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-14 | 2,360,071 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion | 2019-05-13 | 2019-05-14 | 2,360,071 | — | $0 | 2,360,071 | SEC↗ |
| CRTX Cortexyme, Inc. | P Buy | 2019-05-13 | 2019-05-14 | 50,000 | $17.00 | $850.0K | 3,249,973 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion | 2019-05-13 | 2019-05-14 | 624,205 | — | $0 | 3,199,973 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion | 2019-05-13 | 2019-05-14 | 215,697 | — | $0 | 2,575,768 | SEC↗ |
| ICUI ICU MEDICAL INC/DE | S Sale | 2018-11-15 | 2018-11-16 | 2,500,000 | $209.25 | $523.13M | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | C Conversion deriv | 2018-10-15 | 2018-10-17 | 4,185,997 | — | $0 | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | P Buy | 2018-10-15 | 2018-10-17 | 55,556 | $18.00 | $1.00M | 22,032,040 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | C Conversion | 2018-10-15 | 2018-10-17 | 21,976,484 | — | $0 | 21,976,484 | SEC↗ |
| ICUI ICU MEDICAL INC/DE | S Sale | 2018-08-13 | 2018-08-15 | 700,000 | $284.35 | $199.05M | 2,500,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 447,514 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 940,125 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 940,125 | — | $0 | 1,387,639 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2017-10-10 | 2017-10-10 | 40,000 | $17.00 | $680.0K | 1,427,639 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 447,514 | — | $0 | 447,514 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-07 | 714,285 | $7.00 | $5.00M | 2,253,509 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-07 | 235,855 | $7.00 | $1.65M | 2,489,364 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-07 | 491,418 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-07 | 1,047,806 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-07 | 1,539,224 | — | $0 | 1,539,224 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 18 | $29.00 | $522 | 1,235,312 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 11,627 | $38.49 | $447.5K | 1,161,469 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 12,726 | $25.32 | $322.2K | 1,148,743 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 13,109 | $26.32 | $345.0K | 1,135,634 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 25,931 | $20.35 | $527.7K | 1,109,703 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 31,400 | $24.31 | $763.3K | 1,078,303 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 10,544 | $36.37 | $383.5K | 1,173,096 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 9,901 | $37.23 | $368.6K | 1,183,640 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 9,142 | $39.52 | $361.3K | 1,193,541 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 8,969 | $21.45 | $192.4K | 1,202,683 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 8,565 | $27.36 | $234.3K | 1,211,652 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 6,073 | $40.30 | $244.7K | 1,220,217 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 3,207 | $35.61 | $114.2K | 1,226,290 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 2,975 | $28.47 | $84.7K | 1,229,497 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 2,840 | $41.25 | $117.2K | 1,232,472 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 44,268 | $22.60 | $1.00M | 1,034,035 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | S Sale | 2015-08-10 | 2015-08-12 | 58,632 | $23.41 | $1.37M | 975,403 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 301,005 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 327,178 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 334,420 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion | 2014-03-12 | 2014-03-14 | 962,603 | — | $0 | 962,603 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | P Buy | 2014-03-12 | 2014-03-14 | 272,727 | $11.00 | $3.00M | 1,235,330 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 11,812,438 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 1,904,905 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 234,306 | — | $0 | 1,687,250 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 1,452,944 | — | $0 | 1,452,944 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 532,818 | — | $0 | 0 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 19,289,531 | — | $0 | 0 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 42,659 | — | $0 | 42,659 | SEC↗ |
| CLDN Celladon Corp | C Conversion deriv | 2014-02-04 | 2014-02-06 | 23,145 | $8.00 | $185.2K | 0 | SEC↗ |
| CLDN Celladon Corp | C Conversion | 2014-02-04 | 2014-02-06 | 1,544,397 | — | $0 | 1,544,397 | SEC↗ |
| CLDN Celladon Corp | C Conversion | 2014-02-04 | 2014-02-06 | 23,145 | $8.00 | $185.2K | 1,567,542 | SEC↗ |
| CLDN Celladon Corp | P Buy | 2014-02-04 | 2014-02-06 | 227,261 | $8.00 | $1.82M | 1,794,803 | SEC↗ |
| ZTS Zoetis Inc. | C Conversion deriv | 2013-06-24 | 2013-06-26 | 400,985,000 | — | $0 | 0 | SEC↗ |
| ZTS Zoetis Inc. | J Other | 2013-06-24 | 2013-06-26 | 400,985,000 | — | $0 | 0 | SEC↗ |
| ZTS Zoetis Inc. | C Conversion | 2013-06-24 | 2013-06-26 | 400,985,000 | — | $0 | 400,985,000 | SEC↗ |
| ZTS Zoetis Inc. | C Conversion deriv | 2013-02-06 | 2013-02-08 | 12,915,000 | — | $0 | 400,985,000 | SEC↗ |
| ZTS Zoetis Inc. | S Sale | 2013-02-06 | 2013-02-08 | 99,015,000 | — | $0 | 0 | SEC↗ |
| ZTS Zoetis Inc. | C Conversion | 2013-02-06 | 2013-02-08 | 12,915,000 | — | $0 | 12,915,000 | SEC↗ |